These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date Terminated||2007-005166-12||A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients with Mild to Moderate Active Ulcerative Colitis with or without Mesalamine||bad-data|
|Ongoing||2020-000158-88||A Global, Multi Center, Randomized, Placebo-Controlled Phase 3 Trial to Compare the Efficacy and Safety of Fruquintinib Plus Best Supportive Care to Placebo Plus Best Supportive Care in Patients with ...||not-yet-due|
|Ongoing||2020-006118-19||An Open-Label Phase 2 Study of Surufatinib in Patients with Neuroendocrine Tumours in Europe||not-yet-due|